ADCOMS: a composite clinical outcome for prodromal Alzheimer's disease trials

BACKGROUND: Development of new therapies for Alzheimer's disease (AD) is increasingly focused on more mildly affected populations, and requires new assessment and outcome strategies. Patients in early stages of AD have mild cognitive decline and no, or limited, functional impairment. To respond...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Neurol Neurosurg Psychiatry
Main Authors: Wang, Jinping, Logovinsky, Veronika, Hendrix, Suzanne B, Stanworth, Stephanie H, Perdomo, Carlos, Xu, Lu, Dhadda, Shobha, Do, Ira, Rabe, Martin, Luthman, Johan, Cummings, Jeffrey, Satlin, Andrew
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Publishing Group 2016
Assuntos:
Neurodegeneration
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5013117/
https://ncbi.nlm.nih.gov/pubmed/27010616
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jnnp-2015-312383
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados